Vistin Pharma — Director's Dealing 2023

May 30, 2023

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Ferncliff Listed DAI AS has on 30 May 2023 purchased 250,000 shares in Vistin

Pharma ASA at NOK 23.12 per share.

After the transaction Ferncliff Listed DAI AS has a holding of 1,034,280 shares,

corresponding to 2,33% ownership. Ferncliff Listed DAI AS are closely associated

with board member Øystein Stray Spetalen.